Synarel (Nafarelin)

Nafarelin is a medication used to treat certain hormone-related conditions. It helps control the release of hormones that trigger puberty early in children. It's also sometimes used to treat endometriosis, a condition where tissue similar to the uterine lining grows outside the uterus.

Brand names:Synarel
Medication

What people taking Synarel (Nafarelin) report

Every report comes from a Lived member, sent anonymously.

Have you tried Synarel (Nafarelin) for Precocious Puberty?

NameHow it went

About Synarel (Nafarelin)

What It's For

Nafarelin, sold as Synarel, is a prescription nasal spray that temporarily switches off the hormone signals that drive the ovaries and testes. It has two approved uses, at very different doses. In children, it treats central precocious puberty, in which the brain starts puberty too early (signs before about age 8 in girls or age 9 in boys). Pausing puberty aims to halt early body changes and slow the rapid bone maturation that can otherwise end growth early and leave a child shorter as an adult. Not every child with early puberty needs treatment: some, particularly girls close to the usual age whose changes progress slowly, reach a normal adult height without it. In adults 18 and older, nafarelin treats endometriosis, a condition in which tissue similar to the lining of the uterus grows outside it and causes pelvic pain, painful periods and pain with sex. It is used as a single six-month course to relieve pain and shrink the endometriosis patches. Nafarelin belongs to a group of medicines called gonadotropin-releasing hormone (GnRH) agonists. Other medicines in this group are given as injections that last weeks to months, so a twice-daily spray is one option among several.

How It Works

GnRH is a hormone made in the brain. Released in pulses, it tells the pituitary gland to make two hormones, luteinizing hormone (LH) and follicle-stimulating hormone (FSH), which in turn drive the ovaries to make estrogen and the testes to make testosterone. Nafarelin is a stronger, longer-lasting version of GnRH. At first it pushes the pituitary to release more LH and FSH, so sex hormones briefly rise. With steady daily use the pituitary stops responding, and within about four weeks estrogen or testosterone falls to low levels. In a child, low sex hormones pause puberty. In endometriosis, the misplaced tissue depends on estrogen to grow and bleed, so lowering estrogen quiets it and usually stops periods. The effect is reversible: normal hormone production usually returns within 4 to 8 weeks of stopping.

Dosage & Administration

Synarel comes as a nasal spray with a pump that delivers a measured dose. It is used every day, morning and evening, and the amount depends on the condition being treated. For endometriosis, the usual dose is one spray into one nostril in the morning and one spray into the other nostril in the evening, starting between day 2 and day 4 of a menstrual period. If regular periods continue after two months despite consistent use, the prescriber may double the dose. A bottle lasts about a month at the standard endometriosis dose. For central precocious puberty, the dose is much higher: usually two sprays into each nostril in the morning and again in the evening, eight sprays a day, sometimes increased to nine sprays a day split into three doses. At this dose a bottle lasts about a week, so refills need planning. Missed or irregular doses can let puberty hormones rebound, and having a parent or caregiver give the sprays can help keep doses on track. Tilt the head back slightly and wait about 30 seconds between sprays. Try not to sneeze during or right after a dose, since that may reduce how much medicine is absorbed. If a decongestant nasal spray is needed for a cold, use it at least two hours after a Synarel dose.

Side Effects

In adults treated for endometriosis, most side effects come from low estrogen and resemble menopause: hot flashes, headaches, mood swings, lower sex drive, vaginal dryness, acne, muscle aches and a decrease in breast size. These fade after treatment ends. Nasal irritation affects about 1 in 10 users. Ovarian cysts can form in the first two months, more often in people with polycystic ovaries, and usually resolve on their own. In children, the most common effects come from the brief hormone rise at the start: acne, breast enlargement, vaginal bleeding, body odor and moodiness, mostly in the first six weeks. Hot flashes are uncommon in children. Bleeding or breast changes that have not settled by the end of the second month are worth raising with the doctor, since they can mean doses are being missed or the cause of early puberty needs another look. Mood changes, including new or worsening depression, have been reported in adults and children using this group of medicines, and rarely suicidal thoughts. Contact the prescriber promptly about worsening mood or any thoughts of self-harm. Seizures have also been reported, more often in people with a seizure history or other brain conditions. In children, a rare rise in pressure around the brain (pseudotumor cerebri) can cause headaches with blurred or double vision, pain behind the eyes or ringing in the ears; tell the care team if these appear. Very rarely, usually within two weeks of the first dose, a person with an undiagnosed growth on the pituitary gland can have bleeding or loss of blood supply in the gland, called pituitary apoplexy. A sudden severe headache with vomiting, vision changes or confusion needs emergency care right away.

Interactions & Warnings

Synarel must not be used during pregnancy, because it may harm a developing baby, or while breastfeeding. Pregnancy is ruled out before treatment starts. Although the spray usually stops ovulation, it is not reliable birth control, especially when doses are missed, so adults should use a nonhormonal method of contraception, such as condoms, throughout treatment. Anyone who thinks they may be pregnant should stop the spray and contact the prescriber. It is also not used when there is abnormal vaginal bleeding that has not been diagnosed. Low estrogen thins bone. After a six-month endometriosis course, spine bone density fell by roughly 3 to 9 percent on average, depending on how it was measured, and only part of that loss had recovered six months later. That is why endometriosis treatment is limited to one six-month course and repeat courses are not recommended. People with added risk for weak bones, such as heavy alcohol or tobacco use, a strong family history of osteoporosis, or long-term steroid or anti-seizure medicines, should weigh this carefully with their doctor. If a second course is ever considered, bone density is checked first. Synarel has few drug interactions, because the body breaks it down without relying on the liver enzymes involved in most interactions. Medicines that have been linked to seizures, such as bupropion (an antidepressant also used to help stop smoking) and selective serotonin reuptake inhibitor (SSRI) antidepressants, are worth reviewing with the prescriber. Blood tests of reproductive hormones can be misleading during treatment and for 4 to 8 weeks after stopping, so mention Synarel before any fertility or hormone testing.

What to Expect

For endometriosis, estrogen falls over about four weeks and periods usually stop. Some spotting can happen early on, but regular periods that continue past two months should be reported, since they often mean missed doses or a dose that needs raising. Studies of this group of medicines have measured pain improvement after about three months, with modest benefit compared with placebo; the quality of that evidence is low, and responses vary. Endometriosis symptoms can return after the course ends. Because a repeat course is not recommended, it helps to agree on a longer-term plan before finishing. For a child, the doctor watches closely over the first couple of months to confirm that puberty is being suppressed, and reviews growth and bone age within three to six months. Breast or genital development typically stops or goes back, growth slows toward a normal rate for age, and predicted adult height often improves over the first two to three years. Pubic hair may keep developing, because it is driven by adrenal hormones that nafarelin does not affect. Treatment continues until the family and doctor decide puberty should resume; current guidance suggests usually not continuing beyond about age 10 to 11 in girls or 11 to 12 in boys. In studies, puberty restarted in every child followed for a year after stopping. The effect of long-term use on later fertility has not been established.

Questions to Ask Your Doctor

  1. 1.How likely is treatment to make a real difference to my child's adult height or wellbeing, and would watching for a few months first be reasonable?
  2. 2.Would a longer-acting injection suit us better than a spray that has to be used every morning and evening?
  3. 3.How will we know the spray is working, and what should we do if doses are missed?
  4. 4.Which nonhormonal birth control should I use during treatment, and what should I do if I think I might be pregnant?
  5. 5.What is the plan for my endometriosis after the six-month course ends, and should my bone density be checked?

Last reviewed • Oct 2026

Educational content, not medical advice.